Lesiones de la válvula mitral

  1. Moya Mur, J.L.
  2. Reyes Villanes, J.S.
  3. Román, A. Carbonell San
  4. García Martín, A.
  5. Izurieta, C.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Año de publicación: 2017

Serie: 12

Número: 40

Páginas: 2345-2356

Tipo: Artículo

DOI: 10.1016/J.MED.2017.09.001 DIALNET GOOGLE SCHOLAR

Otras publicaciones en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumen

Resumen Las lesiones mitrales constituyen una de las partes fundamentales de las enfermedades cardíacas. Se clasifican en base a su disfunción en estenosis e insuficiencias. La estenosis mitral de etiología reumática, todavía frecuente en países en vías de desarrollo, está siendo sustituida por la de origen degenerativo, cuyo diagnóstico y manejo difiere del de las reumáticas. En la insuficiencia mitral hay que distinguir dos entidades totalmente distintas: las insuficiencias mitrales primarias u orgánicas, en las que el aparato valvular está afectado, y las insuficiencias mitrales secundarias o funcionales en las que la válvula es normal pero se produce insuficiencia porque la disfunción ventricular impide el adecuado cierre de la válvula. El tratamiento de las lesiones mitrales ha cambiado notablemente en los últimos años. El habitual recambio valvular por una prótesis ha sido sustituido por técnicas de reparación valvular. Las técnicas de intervencionismo percutáneo están plenamente establecidas en la estenosis mitral reumática y cobran cada vez más protagonismo en la insuficiencia mitral para casos con alto riesgo quirúrgico.

€ Ver financiación

Información de financiación

Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascuar Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging

Financiadores

Referencias bibliográficas

  • Castillo J, Solís A, Gonzales-Pinto A, Adams D. Ecocardiografía quirúrgica de la válvula mitral. Rev Esp Cardiol. 2011;64(12):1169-81.
  • Zuhlke L, Engel M, Karthikeyan G, RangarajanS, Mackie P, Cupido B. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 2015;36(18):1115-22.
  • Pasca I, Dang P, Tyagi G, Pai R. Survival in patients with degenerative mitral stenosis: results from a large retrospective cohort study. J Am Soc Echocardiogr. 2016;29(5):461-9.
  • Wunderlich N, Beigel R, Siegel R. Management of mitral stenosis using 2D and 3D echo-Doppler imaging. JACC Cardiovasc Imaging. 2013;6(11):1191-205.
  • Oktay A, Gilliland Y, Lavie C, Ramee S, Parrino P, Bates M. Echocardiographic assessment of degenerative mitral stenosis: a diagnostic challenge of an emerging cardiac disease. Curr Probl Cardiol. 2017;42(3):71-100.
  • Baumgartner H, Hung J, Bermejo J, Chambers J, Evangelista A, Griffin B. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10(1):1-25.
  • Nunes M, Tan T, Elmariah S, Do Lago R, Margey R, Cruz-González I. The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergo. Circulation. 2014;129(8):885-95.
  • Vahanian A, Alfieri O, Andreotti F, Antunes M, Barón-Esquivias G, Baumgartner H. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-96.
  • Steuer K, Papadopoulos N, Moritz A, Doss M. Mitral valve surgery in patients with extensively calcified mitral annulus: long term echocardiographic and clinical followup. Herz. 2012;37(7):762-9.
  • Puri R, Abdul-Jawad O, del Trigo M, Campelo-Parada F, Regueiro A, Barbosa H. Transcatheter mitral valve implantation for inoperable severely calcified native mitral valve disease: A systematic review. Catheter Cardiovasc Interv. 2016;87(3):540-8.
  • Enríquez-Sarano M, Avierinos J-F, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med [Internet]. 2005;352(9):875-83.
  • Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C. European association of echocardiography recom-mendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307-32.
  • Carpentier A, Chauvaud S, Fabiani JN, Deloche A, Relland J, Lessana A. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79(3):338-48.
  • Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA. Recommendations for the echocardiographic assessment of native valvular regurgitation: An executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611-44.
  • Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol [Internet]. 2009;54(24):2251-60.
  • Rosen SE, Borer JS, Hochreiter C, Supino P, Roman MJ, Devereux RB. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. Am J Cardiol. 1994;74(4):374-80.
  • Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation implications for management. Circulation. 2008;118(22):2298-303.
  • Fedak PWM, McCarthy PM, Bonow RO. Evolving concepts and technologies in mitral valve repair. Circulation. 2008;117(7):963-74.
  • Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
  • Grigioni F, Enríquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103(13):1759-64.
  • Agricola E, Oppizzi M, Pisani M, Meris A, Maisano F, Margonato A. Ischemic mitral regurgitation: mechanisms and echocardiographic classification. Eur J Echocardiogr. 2008;9(2):207-21.
  • Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538-43.
  • Van Bommel RJ, Marsan NA, Delgado V, Borleffs CJ, van Rijnsoever EP, Schalij MJ. Cardiac resynchronization therapy as a therapeutic option in patients with moderate severe functional mitral regurgitation and high operative risk. Circulation. 2011;124(8):912-9.
  • Magne J, Pibarot P, Dumesnil JG, Sénéchal M. Continued global left ventricular remodeling is not the sole mechanism responsible for the late recurrence of ischemic mitral regurgitation after restrictive annuloplasty. J Am Soc Echocardiogr. 2009;22(11):1256-64.
  • Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138(2):278-85.
  • Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol. 2010;106(3):395-401.
  • Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Pe-rrault LP. Two-Year Outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344-53.
  • Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation. 2009;120(4):326-33.
  • De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400-9.
  • Otto C, Bonow R, editors. Valvular heart disease. A Companion to Braunwald ́s Heart Disease. 4a ed. Filadelfia: Elsevier Saunders; 2014.
  • Lancellotti P, Pibarot P, Chambers J, Edvardsen T, Delgado V, Dulgheru R. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascuar Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:589-636.
  • Dangas G, Weitz J, Giustino G, Makkar R, Mehran R. Prosthetic heart valve thrombosis. J Am Coll Cardiol. 2016;68:2670-89.
  • Pibarot P, Dumesnil J. Prosthetic heart valves: selection of the optimal prosthesis and long term management. Circulation. 2009;119:1034-48.
  • Tanis W, Habets J, van den Brink R, Symersky P, Budde R, Chamuleau S. Differentiation of thrombus fromr pannus as the cause of acquired mechanical prosthetic valve obstruction by non invasive imaging: a review of the literature. Eur Heart J; 2014;15:119-29.
  • Maslow A. Mitral valve repair: An echcoardiographic review: Part 2. J Cardiothorac Vasc Anesth; 2015;29:439-71.
  • Zamorano J, Gonçalves A, Lancellotti P, Andersen K, González-Gómez A, Monaghan M. The use of imaging in new transcatheter interventions: an EACVI review paper. Eur Heart J. 2016;17:835.
  • Muller D, Farivar R, Jansz P, Bae R, Walters D, Clarke A. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation. A global feasibility trial. J Am Coll Cardiol. 2017;69(4):381-91.
Fuente de los datos: Dialnet